Patents Assigned to Lifebond Ltd
  • Patent number: 10202585
    Abstract: Improved matrix or hydrogel that is formed by enzymatic crosslinking of polymers wherein the crosslinking enzyme molecules have been modified for the purpose of improving the crosslinking density, mechanical properties, or other properties of the matrix, and/or to provide improved control over the rate and/or extent of crosslinking, wherein the enzyme molecules are modified to alter the perceived volume of the enzyme molecules in the crosslinked matrix being formed. Methods of production and of use are also provided.
    Type: Grant
    Filed: April 25, 2015
    Date of Patent: February 12, 2019
    Assignee: LIFEBOND LTD
    Inventors: Guy Tomer, Orahn Preiss-Bloom
  • Patent number: 9655988
    Abstract: An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: May 23, 2017
    Assignee: LIFEBOND LTD
    Inventors: Natalie Iram, Orahn Preiss-Bloom, Ishay Attar
  • Patent number: 9636433
    Abstract: An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: May 2, 2017
    Assignee: LIFEBOND LTD
    Inventors: Natalie Iram, Orahn Preiss-Bloom, Ishay Attar
  • Patent number: 8133484
    Abstract: An adhesive material comprising gelatin and a non-toxic cross-linking material such as transglutaminase. The adhesive material is useful for medical purposes as hemostatic products. The hemostatic products are useful for the treatment of wounded tissue.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 13, 2012
    Assignee: Lifebond Ltd
    Inventors: Orahn Preiss-Bloom, Ishay Attar